AcquisitionsNov 4, 2026, 05:32 PM
cbdMD Acquires Twinlab Assets, Diversifies Beyond Hemp
AI Summary
cbdMD, Inc. has successfully completed the acquisition of the operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and ResVitale. This strategic move, finalized through a Florida Chapter 727 assignment for the benefit of creditors, diversifies cbdMD's wellness portfolio beyond hemp-derived products and reduces its reliance on that category. The acquisition brings iconic brands with decades of history in vitamins and nutritional supplements into cbdMD's existing portfolio. The consideration involved assuming senior secured debt, issuing approximately 2.23 million shares of common stock, and a $1.75 million promissory note to Akretive Holdings, LLC.
Key Highlights
- cbdMD, Inc. completed the acquisition of operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and ResVitale brands.
- The acquisition was completed through a Florida Chapter 727 assignment for the benefit of creditors proceeding.
- Consideration included assumption of senior secured debt, issuance of 2,229,805 shares of common stock (19.9% ownership), and additional target percentage shares.
- A Senior Secured Promissory Note of $1,750,000 was issued to Akretive Holdings, LLC, bearing 9% interest and maturing in two years.
- The acquired assets include intellectual property, contracts, permits, inventory, goodwill, and stock of certain Twinlab subsidiaries.
- The acquisition diversifies cbdMD's portfolio beyond hemp-derived products and reduces reliance on that category.
- The company plans to introduce new products and refreshed brand experiences across the combined portfolio.
Price Impact
More from YCBD